<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Urinary <z:chebi fb="0" ids="30860">methylmalonic acid</z:chebi> (<z:chebi fb="0" ids="34840">MMA</z:chebi>) excretion in <z:hpo ids='HP_0001889'>megaloblastic anemia</z:hpo> due to <z:chebi fb="9" ids="17439">vitamin B12</z:chebi> (<z:chebi fb="13" ids="33611">B12</z:chebi>) deficiency was studied using a colorimetric method </plain></SENT>
<SENT sid="1" pm="."><plain>Average <z:chebi fb="0" ids="34840">MMA</z:chebi> excretion in 20 patients with untreated <z:chebi fb="13" ids="33611">B12</z:chebi> deficiency was 164 mg/day, whereas it increased to 518 mg/day following oral administration of 10 g <z:chebi fb="0" ids="16414,30015">L-valine</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Urinary <z:chebi fb="0" ids="34840">MMA</z:chebi> correlated significantly with platelet number, erythroblast percentage and deoxyuridine suppression test, while no correlation was found with <z:chebi fb="0" ids="35143">hemoglobin</z:chebi>, leukocyte number, reticulocyte, serum LDH, serum <z:chebi fb="13" ids="33611">B12</z:chebi> and <z:chebi fb="3" ids="37445">folate</z:chebi> concentration </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with neurological disturbances excreted significantly larger amounts of <z:chebi fb="0" ids="34840">MMA</z:chebi> than those without <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">neurological disorders</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The results also indicated that <z:chebi fb="0" ids="34840">MMA</z:chebi> could be a useful adjunct for differentiation of <z:hpo ids='HP_0001889'>megaloblastic anemia</z:hpo> from <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> showing marked <z:e sem="disease" ids="C0002888" disease_type="Disease or Syndrome" abbrv="">megaloblastic</z:e> changes </plain></SENT>
</text></document>